Kyriakos Kachrimanis (K Kachrimanis)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

Pharmaceutics

Drug development and industrial pharmacy

Biomedicines

Pharmaceuticals (Basel, Switzerland)

Aristotle University of Thessaloniki

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aristotle University of Thessaloniki Oct 22 2001

Greece

Associate Professor :: School of Pharmacy

Publications

Elisavet Vardaka, Kyriakos Kachrimanis
Nanocrystal formulations of mebendazole employing quality by design and molecular level insights by atomistic simulations. Drug development and industrial pharmacy (2024)
E Nikidis, N Kyriakopoulos, R Tohid, Kyriakos Kachrimanis, Joseph Kioseoglou
Harnessing machine learning for efficient large-scale interatomic potential for sildenafil and pharmaceuticals containing H, C, N, O, and S. Nanoscale (2024)
Elisavet Vardaka, Kyriakos Kachrimanis
Nanocrystal formulations of mebendazole employing Quality by Design and molecular level insights by atomistic simulations. Drug development and industrial pharmacy (2024)
Andreas Ouranidis, Christina Davidopoulou, Kyriakos Kachrimanis
Integrating Elastic Tensor and PC-SAFT Modeling with Systems-Based Pharma 4.0 Simulation, to Predict Process Operations and Product Specifications of Ternary Nanocrystalline Suspensions. Pharmaceutics 13 (11) (2021)
Anastasia Tsiaxerli, Anna Karagianni, Andreas Ouranidis, Kyriakos Kachrimanis
Polyelectrolyte Matrices in the Modulation of Intermolecular Electrostatic Interactions for Amorphous Solid Dispersions: A Comprehensive Review. Pharmaceutics 13 (9) (2021)
Andreas Ouranidis, Anastasia Tsiaxerli, Elisavet Vardaka, Catherine K Markopoulou, Constantinos K K Zacharis, Ioannis Nicolaou, Dimitris Hatzichristou, Anna-Bettina Haidich, Nikolaos Kostomitsopoulos, Kyriakos Kachrimanis
Sildenafil 4.0-Integrated Synthetic Chemistry, Formulation and Analytical Strategies Effecting Immense Therapeutic and Societal Impact in the Fourth Industrial Era. Pharmaceuticals (Basel, Switzerland) 14 (4) (2021)
Andreas Ouranidis, Theofanis Vavilis, Evdokia Mandala, Christina Davidopoulou, Eleni Stamoula, Catherine K Markopoulou, Anna Karagianni, Kyriakos Kachrimanis
mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles. Biomedicines 10 (1) (2021)
Andreas Ouranidis, Christina Davidopoulou, Reald-Konstantinos Tashi, Kyriakos Kachrimanis
Pharma 4.0 Continuous mRNA Drug Products Manufacturing. Pharmaceutics 13 (9) (2021)
Ioannis Partheniadis, Ioannis Nikolakakis, Constantinos K K Zacharis, Kyriakos Kachrimanis, Nizar Al-Zoubi
Co-Spray Drying of Paracetamol and Propyphenazone with Polymeric Binders for Enabling Compaction and Stability Improvement in a Combination Tablet. Pharmaceutics 13 (8) (2021)
Andreas Ouranidis, Nikos Gkampelis, Elisavet Vardaka, Anna Karagianni, Dimitrios Tsiptsios, Ioannis Nikolakakis, Kyriakos Kachrimanis
Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation. Pharmaceutics 12 (10) (2020)
Theodoros Avgerinos, Nikolaos Kantiranis, Athanasia Panagopoulou, Stavros Malamataris, Kyriakos Kachrimanis, Ioannis Nikolakakis
Mechanical properties and drug release of venlafaxine HCl solid mini matrices prepared by hot-melt extrusion and hot or ambient compression. Drug development and industrial pharmacy 44 (2) (2017)
P Barmpalexis, P Syllignaki, Kyriakos Kachrimanis
A study of water uptake by selected superdisintegrants from the sub-molecular to the particulate level. Pharmaceutical development and technology 23 (5) (2017)

Kyriakos Kachrimanis.css-eqlu8i{font-size:small;padding-left:4px;} (K Kachrimanis)

Publication Activity (10 Years)

Top Topics

Top Venues

Kyriakos Kachrimanis (K Kachrimanis)